Detail
Článek
Článek online
FT
Medvik - BMČ
  • Je něco špatně v tomto záznamu ?

Longitudinal Trends in Severe Dyslipidemia in the Czech Population: The Czech MONICA and Czech Post-MONICA Study

R. Cífková, J. Bruthans, P. Wohlfahrt, A. Hrubeš Krajčoviechová, P. Šulc, M. Jozífová, L. Eremiášová, J. Pudil, A. Linhart, J. Widimský, J. Filipovský, O. Mayer, R. Poledne, P. Stávek, V. Lánská, L. Strilchuk

. 2023 ; 10 (8) : . [pub] 20230731

Status neindexováno Jazyk angličtina Země Švýcarsko

Typ dokumentu časopisecké články

Perzistentní odkaz   https://www.medvik.cz/link/bmc23015581

Grantová podpora
15-27109A Ministerstvo zdravotnictví ČR

Background: Severe hypercholesterolemia is associated with an increase in the risk of developing atherosclerotic cardiovascular disease. The aim of this analysis was to assess longitudinal trends in severe dyslipidemia (defined as total cholesterol > 8 mmol/L or LDL-cholesterol > 5 mmol/L) in a representative population sample of the Czech Republic and to analyze the longitudinal trends in the basic characteristics of individuals with severe dyslipidemia. Methods: Seven independent cross-sectional surveys were organized in the Czech Republic to screen for major cardiovascular risk factors (from 1985 to 2015-2018). A total of 20,443 randomly selected individuals aged 25-64 years were examined. Results: The overall prevalence of severe dyslipidemia was 6.6%, with a significant downward trend from the fifth survey onwards (2000/2001). Over the study period of 30+ years, the individuals with severe dyslipidemia became older, increased in BMI, and did not change their smoking habits. Total cholesterol and non-HDL-cholesterol decreased significantly in both sexes throughout the duration of the study. Conclusions: Despite a significant improvement in lipids in the Czech Republic from 1985, substantially contributing to the decline in cardiovascular mortality, the number of individuals with severe dyslipidemia remained high, and in most cases, they were newly detected during our screening examinations and were thus untreated.

Citace poskytuje Crossref.org

000      
00000naa a2200000 a 4500
001      
bmc23015581
003      
CZ-PrNML
005      
20240516100355.0
007      
ta
008      
231010s2023 sz f 000 0|eng||
009      
AR
024    7_
$a 10.3390/jcdd10080328 $2 doi
035    __
$a (PubMed)37623341
040    __
$a ABA008 $b cze $d ABA008 $e AACR2
041    0_
$a eng
044    __
$a sz
100    1_
$a Cífková, Renata $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic $u Department of Medicine II, Charles University in Prague, First Faculty of Medicine, 128 08 Prague, Czech Republic $1 https://orcid.org/0000000327653821 $7 nlk20010094490
245    10
$a Longitudinal Trends in Severe Dyslipidemia in the Czech Population: The Czech MONICA and Czech Post-MONICA Study / $c R. Cífková, J. Bruthans, P. Wohlfahrt, A. Hrubeš Krajčoviechová, P. Šulc, M. Jozífová, L. Eremiášová, J. Pudil, A. Linhart, J. Widimský, J. Filipovský, O. Mayer, R. Poledne, P. Stávek, V. Lánská, L. Strilchuk
520    9_
$a Background: Severe hypercholesterolemia is associated with an increase in the risk of developing atherosclerotic cardiovascular disease. The aim of this analysis was to assess longitudinal trends in severe dyslipidemia (defined as total cholesterol > 8 mmol/L or LDL-cholesterol > 5 mmol/L) in a representative population sample of the Czech Republic and to analyze the longitudinal trends in the basic characteristics of individuals with severe dyslipidemia. Methods: Seven independent cross-sectional surveys were organized in the Czech Republic to screen for major cardiovascular risk factors (from 1985 to 2015-2018). A total of 20,443 randomly selected individuals aged 25-64 years were examined. Results: The overall prevalence of severe dyslipidemia was 6.6%, with a significant downward trend from the fifth survey onwards (2000/2001). Over the study period of 30+ years, the individuals with severe dyslipidemia became older, increased in BMI, and did not change their smoking habits. Total cholesterol and non-HDL-cholesterol decreased significantly in both sexes throughout the duration of the study. Conclusions: Despite a significant improvement in lipids in the Czech Republic from 1985, substantially contributing to the decline in cardiovascular mortality, the number of individuals with severe dyslipidemia remained high, and in most cases, they were newly detected during our screening examinations and were thus untreated.
590    __
$a NEINDEXOVÁNO
655    _2
$a časopisecké články $7 D016428
700    1_
$a Bruthans, Jan $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic
700    1_
$a Wohlfahrt, Peter $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic
700    1_
$a Hrubeš Krajčoviechová, Alena $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic $7 xx0095262
700    1_
$a Šulc, Pavel $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic
700    1_
$a Jozífová, Marie $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic
700    1_
$a Eremiášová, Lenka $u Department of Medicine II, Charles University in Prague, First Faculty of Medicine, 128 08 Prague, Czech Republic
700    1_
$a Pudil, Jan $u Department of Medicine II, Charles University in Prague, First Faculty of Medicine, 128 08 Prague, Czech Republic
700    1_
$a Linhart, Aleš $u Department of Medicine II, Charles University in Prague, First Faculty of Medicine, 128 08 Prague, Czech Republic
700    1_
$a Widimský, Jiří $u Department of Medicine III, Charles University in Prague, First Faculty of Medicine, 128 08 Prague, Czech Republic
700    1_
$a Filipovský, Jan $u Department of Medicine II, Faculty of Medicine, Charles University, 301 00 Pilsen, Czech Republic
700    1_
$a Mayer, Otto $u Department of Medicine II, Faculty of Medicine, Charles University, 301 00 Pilsen, Czech Republic
700    1_
$a Poledne, Rudolf $u Atherosclerosis Research Laboratory, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic $1 https://orcid.org/0000000324536611
700    1_
$a Stávek, Petr $u Atherosclerosis Research Laboratory, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
700    1_
$a Lánská, Věra $u Medical Statistics Unit, Institute for Clinical and Experimental Medicine, 140 21 Prague, Czech Republic
700    1_
$a Strilchuk, Larysa $u Center for Cardiovascular Prevention, Charles University in Prague, First Faculty of Medicine and Thomayer University Hospital, 140 59 Prague, Czech Republic $u Department of Therapy No1, Medical Diagnostics, Hematology and Transfusiology, Lviv Danylo Halytsky National Medical University, 79010 Lviv, Ukraine
773    0_
$w MED00194905 $t Journal of cardiovascular development and disease $x 2308-3425 $g Roč. 10, č. 8 (2023)
856    41
$u https://pubmed.ncbi.nlm.nih.gov/37623341 $y Pubmed
910    __
$a ABA008 $b sig $c sign $y - $z 0
990    __
$a 20231010 $b ABA008
991    __
$a 20240516100350 $b ABA008
999    __
$a ok $b bmc $g 1997194 $s 1201943
BAS    __
$a 3
BAS    __
$a PreBMC-PubMed-not-MEDLINE
BMC    __
$a 2023 $b 10 $c 8 $e 20230731 $i 2308-3425 $m Journal of cardiovascular development and disease $n J Cardiovasc Dev Dis $x MED00194905
GRA    __
$a 15-27109A $p Ministerstvo zdravotnictví ČR
LZP    __
$a Pubmed-20231010

Najít záznam

Citační ukazatele

Pouze přihlášení uživatelé

Možnosti archivace